Sol Capital Management CO Gilead Sciences, Inc. Transaction History

Sol Capital Management CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $299,400 - $341,615	-4,990 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$56.65 - $64.55 $2,832 - $3,227	-50 Reduced 0.99%	4,990 $291,000
Q3 2020 Oct 23, 2020	SELL	$62.1 - $78.08 $15,525 - $19,520	-250 Reduced 4.73%	5,040 $318,000
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $15,914 - $18,480	220 Added 4.34%	5,290 $407,000
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $31,315 - $40,110	-500 Reduced 8.98%	5,070 $379,000
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $280,371 - $308,399	-4,550 Reduced 44.96%	5,570 $362,000
Q3 2019 Oct 21, 2019	SELL	$62.51 - $69.0 $54,758 - $60,444	-876 Reduced 7.97%	10,120 $641,000
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $117,553 - $131,822	-1,900 Reduced 14.73%	10,996 $743,000
Q1 2019 Apr 30, 2019	BUY	$62.53 - $70.05 $15,632 - $17,512	250 Added 1.98%	12,896 $838,000
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $28,512 - $31,568	400 Added 3.27%	12,646 $976,000
Q2 2018 Jul 11, 2018	BUY	$64.88 - $75.68 $99,006 - $115,487	1,526 Added 14.24%	12,246 $868,000
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $40,062 - $48,840	550 Added 5.41%	10,720 $808,000
Q4 2017 Jan 31, 2018	SELL	$71.15 - $83.52 $42,690 - $50,112	-600 Reduced 5.57%	10,170 $729,000
Q3 2017 Oct 27, 2017	BUY	$72.11 - $85.47 $776,624 - $920,511	10,770	10,770 $873,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

Stay updated on Sol Capital Management CO with notifications on news.